Leveraging Social Innovation and Community-Engagement to Reduce Disparities in Outbreak Control Outcomes

May 11, 2026 updated by: Wake Forest University Health Sciences

Community-Academic Partnerships to Address Disparities Within Rural and Urban Communities

This study evaluates the impact of an intervention to increase viral transmission behaviors. The intervention will be developed through a crowdsourcing contest.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

NPIs that are community-driven and developed in collaboration with diverse partners, including community members, public health agencies, and researchers may offer an acceptable and effective approach to reducing viral transmission and addressing individual and socio-structural barriers that lead to worse virus-related outcomes. Our study goals are to use a crowdsourcing open call to identify exceptional ideas (e.g., messages, videos, communication and dissemination strategies) that promote disease testing and encourage the public to practice the 3 Ws, referred to as health-promotive behaviors.

Study Type

Observational

Enrollment (Estimated)

546

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • North Carolina
      • Winston-Salem, North Carolina, United States, 27157
        • Recruiting
        • Wake Forest University Health Sciences
        • Contact:
        • Principal Investigator:
          • Tiarney D Ritchwood, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

NC residents residing in urban and rural communities

Description

Inclusion Criteria:

  • specific zip codes in North Carolina (specific zip codes to be determined)
  • no self-reported history of COVID-19 infection
  • have not tested within the past 14 days

Exclusion Criteria:

  • live outside of study area
  • under 18

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Crowdsourced campaign package
Disease prevention intervention developed using a crowdsourcing process.
Behavioral: Crowdsourced campaign package
Disease prevention intervention developed using a crowdsourcing process.
Rapid Response Team
Pilot a new hybrid training focused on contact tracing and case investigation.
Behavioral: Rapid Response Teams
Pilot a new hybrid training focused on contact tracing and case investigation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants enrolled as measured by enrollment log
Time Frame: Up to 3 years
Number of participants enrolled as measured by enrollment log
Up to 3 years
Number of participants rating intervention as acceptable as measured by a post-intervention questionnaire
Time Frame: Up to 4 years
Number of participants rating intervention as acceptable as measured by a post-intervention questionnaire
Up to 4 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Wake Forest University Health Sciences

Investigators

  • Principal Investigator: Tiarney Ritchwood, PhD, Wake Forest University Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2024

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

August 31, 2027

Study Registration Dates

First Submitted

November 15, 2021

First Submitted That Met QC Criteria

November 15, 2021

First Posted (Actual)

November 17, 2021

Study Record Updates

Last Update Posted (Actual)

May 12, 2026

Last Update Submitted That Met QC Criteria

May 11, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB00099888
  • 40010565 (Other Identifier: National Institutes of Health)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Outbreak Investigation

Clinical Trials on Crowdsourced campaign package

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe